Shire Pharmaceuticals Ireland Ltd.
www.shire.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Shire Pharmaceuticals Ireland Ltd.
Takeda’s Maribavir For Post-Transplant Cytomegalovirus Might See Split Panel Vote
First-in-class CMV treatment showed better efficacy in refractory patients with genetic resistance than those without; US FDA advisory committee will separately consider benefit-risk in each type of patient. On the safety side, taste disturbance is the only adverse event that stands out.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice